Search

Search Constraints

You searched for: Author/Creator Westermann, Anneke

Search Results

1. 596 A randomised phase II study of nintedanib (BIBF1120) compared to chemotherapy in patients with recurrent clear cell carcinoma of the ovary or endometrium. (NICCC/ENGOT-OV36). (14th December 2020)

3. 2022-RA-1548-ESGO Trial in progress update on ENGOT-cx8/GOG-3024/innovaTV 205: addition of a new cohort using first-line tisotumab vedotin + pembrolizumab + carboplatin ± bevacizumab in recurrent/metastatic cervical cancer. (20th October 2022)

5. TP004/#1457 Trial in progress of engot-CX8/GOG-3024/innovaTV 205: addition of a new cohort using first-line tisotumab vedotin + pembrolizumab + carboplatin ± bevacizumab in recurrent/metastatic cervical cancer. (4th December 2022)

6. The European Network for Gynaecological Oncological Trial Groups Charta for Privileged Partnership. Issue 6 (1st July 2015)

7. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. Issue 1 (January 2021)

8. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. (January 2021)

9. The European Network for Gynaecological Oncological Trial Groups Charta for Privileged Partnership. Issue 6 (July 2015)

10. The European Network for Gynaecological Oncological Trial Groups Charta for Privileged Partnership. Issue 6 (July 2015)